Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Future Cardiology
(ISSN: 1479-6678,1744-8298)
This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.
The complex antiplatelet therapy landscape makes it difficult to identify the optimal aspirin dose for minimizing risk, while complying with the clinical guidelines.
After nearly 50 years CABG now has the most solid evidence supporting its role in revascularization for stable ischemic heart disease -- in its history.
Learn why recent studies on the use of dabigatran in patients with atrial fibrillation have suggested a new potential role for dabigatran in patients with mechanical heart valves.
Long-term oral anticoagulant and dual-antiplatelet therapy are commonly needed in patients with atrial fibrillation and in patients undergoing PCI, respectively.
Hypertrophic cardiomyopathy is a genetic disease characterized by abnormal myocardial hypertrophy, which can lead to a wide clinical spectrum, including sudden cardiac death and heart failure. Find out the best ways to diagnose it.
The complexities of managing coexisting heart disease and cancer are examined in an attempt to outline strategic principles for providing optimal care.
Individuals with pre-existing congenital, inherited or acquired heart conditions may experience functional cardiac deterioration or sudden death - even during moderate exertion. What precautions should we take?
Surgeons and cardiologists have been trying for years to replace mitral valve surgery via full sternotomy, with minimal access and percutaneous interventions. Are we there yet?
